Yang Chunlan, Wang Xiaodong, Wang Chunjing, Zhang Xiaoling, Li Yue, Yu Yue, Liu Sixi
Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong 518000, China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 Oct 10;38(10):993-996. doi: 10.3760/cma.j.cn511374-20200408-00247.
To investigate the genetic etiology, clinical diagnosis and treatment of a child with pancytopenia, failure to thrive and pulmonary infection.
Peripheral blood samples of the child and her parents were collected. Genomic DNA was extracted. Genetic variants associated with hematological diseases were detected by high-throughput sequencing.
Three variants of TCN2 gene were found, one of which located in exon 5 upstream(c.581-8A>T), the parents has carried this variant; one in exon 6 (c.924_927del), the variant was originated from the mother; one in exon 7 (c.973C>T), the variant has ocurred de novo. The variants pathogenic analysis combined with clinical manifestation, pancytopenia, the increase in methylmalonic acid level and increased homocysteine, the child was diagnosed with transcobalaminIIdeficiency. The patient presented with respiratory infection, which was confirmed to be pneumocystosis by lung radioscopy and pathogenic high-throughput sequencing of broncho-alveolar lavage fluid. The patient presented with acute respiratory distress syndrome during the treatment with intramuscular injection of vitamin B, and improved after anti-infection with compound sulfamethoxazole and symptomatic support treatment.
We reported a case of Chinese child with TCNII deficiency due to novel gene variant, and analyzed the pathogenicity of the three variants. The treatment of TCNII deficiency with cobalamin should be individualized.
探讨一名全血细胞减少、生长发育迟缓并伴有肺部感染患儿的遗传病因、临床诊断及治疗方法。
采集患儿及其父母的外周血样本,提取基因组DNA,采用高通量测序检测与血液系统疾病相关的基因变异。
发现TCN2基因的三个变异,其中一个位于外显子5上游(c.581-8A>T),父母均携带该变异;一个位于外显子6(c.924_927del),该变异来自母亲;一个位于外显子7(c.973C>T),此变异为新发。结合临床表现、全血细胞减少、甲基丙二酸水平升高及同型半胱氨酸增加进行变异致病性分析,该患儿被诊断为转钴胺素II缺乏症。患儿出现呼吸道感染,经肺部透视及支气管肺泡灌洗液致病性高通量测序确诊为肺孢子菌病。患儿在肌肉注射维生素B治疗过程中出现急性呼吸窘迫综合征,经复方磺胺甲恶唑抗感染及对症支持治疗后好转。
报道1例因新基因变异导致转钴胺素II缺乏症的中国患儿,并分析了三个变异的致病性。转钴胺素II缺乏症的钴胺素治疗应个体化。